Humoral and Cellular Immunity in First-cycle SARS-CoV-2 Vaccinated COVID-19 Patients

NCT05338736 · clinicaltrials.gov ↗

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

SARS CoV 2 Infection
COVID-19

Interventions

DIAGNOSTIC_TEST: LIAISON SARS-CoV-2 TrimericS IgG (DiaSorin)
DIAGNOSTIC_TEST: LIAISON SARS-CoV2-IgM (DiaSorin)
DIAGNOSTIC_TEST: Human IFN-g ELISpot PLUS (ALP) (AUROGENE)

Sponsor

University Magna Graecia